8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
Mar 5, 2026·SEC
Material company update
Jan 12, 2026·SEC
Omada Health(OMDA)Earnings, Financials & Key Ratios
OMDA•NASDAQ
Price updated Jun 19, 2026
AboutOmada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.Show more
- Revenue$260M+53.2%
- EBITDA-$6M+83.3%
- Net Income-$13M+72.9%
- EPS (Diluted)-0.22+74.1%
- Gross Margin65.69%+8.4%
- EBITDA Margin-2.49%+89.1%
- Operating Margin-4.6%+82.1%
- Net Margin-4.91%+82.3%
- ROE-8.68%+84.9%
OMDA Key Insights
Omada Health (OMDA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 80 (top 20%)
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when OMDA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
OMDA Price & Volume
Omada Health (OMDA) stock price & volume — 10-year historical chart
Loading chart...
OMDA Growth Metrics
Omada Health (OMDA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years42.89%
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-
Return on Capital
10 Years-31.41%
5 Years-31.41%
3 Years-29.01%
Last Year-7.33%
OMDA Recent Earnings
Omada Health (OMDA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/4 qtrs (100%)●Beat Revenue 3/4 qtrs (75%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.01+107.8%
$0.13
Rev
$78M+5.3%
$74M
Q2 2026
Mar 5, 2026Metric
Actual
Est
EPS
$0.13+1427.6%
$0.01
Rev
$76M+8.0%
$70M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.02+120.0%
$0.10
Rev
$68M-1.5%
$69M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.09+10.0%
$0.10
Rev
$61M+10.7%
$55M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.01vs $0.13+107.8% | $78Mvs $74M+5.3% |
| Q2 2026 | Mar 5, 2026 | $0.13vs $0.01+1427.6% | $76Mvs $70M+8.0% |
| Q4 2025 | Nov 6, 2025 | $0.02vs $0.10+120.0% | $68Mvs $69M-1.5% |
| Q3 2025 | Aug 7, 2025 | $0.09vs $0.10+10.0% | $61Mvs $55M+10.7% |
Based on last 4 quarters of dataView full earnings history →
OMDA Peer Comparison
Omada Health (OMDA) competitors in Virtual Care and Digital Programs — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 TDOC | 1.46B | 8.07 | -7.08 | -1.54% | -6.81% | -12.37% | 0.75 | |
 OPRX | 93.45M | 4.98 | 18.44 | 18.78% | 6.37% | 5.47% | 0.20 | |
 GDRX | 922.03M | 2.66 | 31.18 | 0.57% | 3.74% | 4.75% | 0.10 | |
 PHVS | 2.15B | 32.80 | -9.60 | -67.38% | 0.00 | |||
 DOCS | 3.83B | 20.46 | 20.88 | 13.05% | 30.4% | 19.36% | 0.01 | |
 AMWL | 140.85M | 8.43 | -1.41 | -1.98% | -48.16% | -33.48% | 0.02 |
Compare OMDA vs Peers
Omada Health (OMDA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
OMDA Income Statement
Omada Health (OMDA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|
Sales/Revenue | 89.19M | 122.78M | 169.8M | 260.21M | 283.3M |
Revenue Growth % | - | 37.67% | 38.29% | 53.24% | - |
Cost of Goods Sold | 46.39M | 52.81M | 66.92M | 89.27M | 95.69M |
COGS % of Revenue | 52.02% | 43.01% | 39.41% | 34.31% | - |
Gross Profit | 42.79M▲ 0% | 69.97M▲ 63.5% | 102.88M▲ 47.0% | 170.94M▲ 66.2% | 187.6M▲ 0% |
Gross Margin % | 47.98% | 56.99% | 60.59% | 65.69% | 66.22% |
Gross Profit Growth % | - | 63.52% | 47.03% | 66.16% | - |
Operating Expenses | 115.14M | 135.97M | 146.53M | 182.91M | 195.96M |
OpEx % of Revenue | 129.1% | 110.74% | 86.3% | 70.29% | - |
Selling, General & Admin | 88.97M | 102.23M | 110.61M | 142.23M | 114.04M |
SG&A % of Revenue | 99.76% | 83.26% | 65.14% | 54.66% | - |
Research & Development | 26.17M | 33.74M | 35.92M | 40.68M | 32.6M |
R&D % of Revenue | 29.34% | 27.48% | 21.16% | 15.63% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 1000K |
Operating Income | -72.35M▲ 0% | -66M▲ 8.8% | -43.65M▲ 33.9% | -11.97M▲ 72.6% | -8.36M▲ 0% |
Operating Margin % | -81.12% | -53.75% | -25.71% | -4.6% | -2.95% |
Operating Income Growth % | - | 8.78% | 33.85% | 72.58% | - |
EBITDA | -68.02M | -61.55M | -38.85M | -6.48M | -2.69M |
EBITDA Margin % | -76.27% | -50.13% | -22.88% | -2.49% | -0.95% |
EBITDA Growth % | - | 9.51% | 36.88% | 83.32% | - |
D&A (Non-Cash Add-back) | 4.33M | 4.45M | 4.8M | 5.49M | 5.67M |
EBIT | -68.32M | -62.81M | -42.63M | -10.24M | -7M |
Net Interest Income | -2M | 1.07M | -3.7M | 2.77M | 5.11M |
Interest Income | 2.2M | 5.78M | 805K | 5.3M | 6.59M |
Interest Expense | 4.2M | 4.71M | 4.51M | 2.53M | 1.48M |
Other Income/Expense | -168K | -1.51M | -3.48M | -806K | 2.06M |
Pretax Income | -72.52M▲ 0% | -67.51M▲ 6.9% | -47.14M▲ 30.2% | -12.78M▲ 72.9% | -6.3M▲ 0% |
Pretax Margin % | -81.31% | -54.98% | -27.76% | -4.91% | -2.22% |
Income Tax | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% |
Net Income | -72.52M▲ 0% | -67.51M▲ 6.9% | -47.14M▲ 30.2% | -12.78M▲ 72.9% | -6.3M▲ 0% |
Net Margin % | -81.31% | -54.98% | -27.76% | -4.91% | -2.22% |
Net Income Growth % | - | 6.9% | 30.18% | 72.89% | - |
Net Income (Continuing) | -72.52M | -67.51M | -47.14M | -12.78M | -6.3M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1.30▲ 0% | -1.21▲ 6.9% | -0.85▲ 29.8% | -0.22▲ 74.1% | -0.11▲ 0% |
EPS Growth % | - | 6.92% | 29.75% | 74.12% | - |
EPS (Basic) | -1.30 | -1.21 | -0.85 | -0.22 | - |
Diluted Shares Outstanding | 55.74M | 55.74M | 55.74M | 58.43M | 58.92M |
Basic Shares Outstanding | 55.74M | 55.74M | 55.74M | 58.43M | 58.92M |
Dividend Payout Ratio | - | - | - | - | - |
OMDA Balance Sheet
Omada Health (OMDA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|
Total Current Assets | 188.56M | 142.88M | 113.06M | 272.93M | 269.43M |
Cash & Short-Term Investments | 168.12M | 115.64M | 76.39M | 222.04M | 211.76M |
Cash Only | 168.12M | 115.64M | 76.39M | 222.04M | 211.76M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 11.67M | 16.44M | 23.92M | 34.59M | 39.98M |
Days Sales Outstanding | 47.75 | 48.87 | 51.42 | 48.51 | 48.09 |
Inventory | 3.54M | 3.61M | 3.3M | 4.49M | 3.83M |
Days Inventory Outstanding | 27.85 | 24.98 | 17.98 | 18.34 | 14.24 |
Other Current Assets | 2.26M | 3.91M | 5.16M | 11.83M | 13.85M |
Total Non-Current Assets | 33.24M | 32.2M | 37.83M | 32.47M | 33.37M |
Property, Plant & Equipment | 6.06M | 5.6M | 6.07M | 7.94M | 8.46M |
Fixed Asset Turnover | 14.71x | 21.93x | 27.96x | 32.76x | 37.17x |
Goodwill | 13.24M | 13.24M | 13.24M | 13.24M | 13.24M |
Intangible Assets | 8.31M | 6.27M | 4.26M | 2.41M | 1.98M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 5.63M | 7.09M | 14.26M | 8.88M | 9.7M |
Total Assets | 221.8M▲ 0% | 175.08M▼ 21.1% | 150.89M▼ 13.8% | 305.41M▲ 102.4% | 302.8M▲ 0% |
Asset Turnover | 0.40x | 0.70x | 1.13x | 0.85x | 0.95x |
Asset Growth % | - | -21.06% | -13.82% | 102.4% | 114.47% |
Total Current Liabilities | 34.51M | 43.79M | 53.95M | 75.73M | 68.68M |
Accounts Payable | 4.11M | 3.62M | 4.17M | 10.28M | 8.1M |
Days Payables Outstanding | 32.31 | 25.03 | 22.73 | 42.02 | 29.68 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue (Current) | 13.44M | 14.88M | 19.53M | 25.06M | 79.94M |
Other Current Liabilities | 9.99M | 15.49M | 21.12M | 40.39M | 31.23M |
Current Ratio | 5.46x | 3.26x | 2.10x | 3.60x | 3.92x |
Quick Ratio | 5.36x | 3.18x | 2.03x | 3.54x | 3.87x |
Cash Conversion Cycle | 43.29 | 48.82 | 46.66 | 24.84 | 32.65 |
Total Non-Current Liabilities | 31.68M | 32.37M | 32.31M | 0 | 0 |
Long-Term Debt | 28.89M | 29.38M | 29.77M | 0 | 0 |
Capital Lease Obligations | 1.27M | 411K | 0 | 0 | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1.52M | 2.58M | 2.54M | 0 | 0 |
Total Liabilities | 66.19M | 76.16M | 86.26M | 75.73M | 68.68M |
Total Debt | 30.81M | 30.58M | 30.19M | 0 | 0 |
Net Debt | -137.31M | -85.06M | -46.21M | -222.04M | -211.76M |
Debt / Equity | 0.20x | 0.31x | 0.47x | - | 0.00x |
Debt / EBITDA | - | - | - | - | -0.00x |
Net Debt / EBITDA | - | - | - | - | 78.69x |
Interest Coverage | -16.26x | -13.35x | -9.46x | -4.04x | -4.74x |
Total Equity | 155.6M▲ 0% | 98.92M▼ 36.4% | 64.63M▼ 34.7% | 229.68M▲ 255.4% | 234.12M▲ 0% |
Equity Growth % | - | -36.43% | -34.66% | 255.37% | 296.91% |
Book Value per Share | 2.79 | 1.77 | 1.16 | 3.93 | 3.97 |
Total Shareholders' Equity | 155.6M | 98.92M | 64.63M | 229.68M | 234.12M |
Common Stock | 21K | 7K | 8K | 58K | 59K |
Retained Earnings | -329.32M | -396.83M | -443.97M | -456.74M | -459.71M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
OMDA Cash Flow Statement
Omada Health (OMDA) cash flow — operating, investing & free cash flow history
| Metric | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|
Cash from Operations | -68.98M | -49.74M | -34.18M | 18.25M | 22.54M |
Operating CF Margin % | -77.34% | -40.51% | -20.13% | 7.01% | - |
Operating CF Growth % | - | 27.89% | 31.28% | 153.4% | 26.58% |
Net Income | -72.52M | -67.51M | -47.14M | -12.78M | -6.3M |
Depreciation & Amortization | 4.33M | 4.45M | 4.8M | 5.49M | 6.61M |
Stock-Based Compensation | 6.65M | 8.74M | 9.42M | 12.96M | 10.78M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 1.7M | 6.08M | 5.3M | 8.85M | 30.95M |
Working Capital Changes | -9.14M | -1.5M | -6.57M | 3.74M | -1.57M |
Change in Receivables | -3.93M | -5.34M | -8.8M | -12.36M | -12.07M |
Change in Inventory | -1.95M | -74K | 318K | -1.19M | -789K |
Change in Payables | -4.99M | -286K | 399K | 6.29M | 3.52M |
Cash from Investing | -2.72M | -2.92M | -3.86M | -5.83M | -6.14M |
Capital Expenditures | -720K | -416K | -596K | -1.32M | -2.06M |
CapEx % of Revenue | 0.81% | 0.34% | 0.35% | 0.51% | 0.73% |
Acquisitions | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - |
Other Investing | -2M | -2.5M | -3.27M | -4.51M | -4.08M |
Cash from Financing | 16.32M | 179K | -1.21M | 133.22M | 135.97M |
Debt Issued (Net) | -1.27M | 963K | 0 | -30.96M | 1.43M |
Equity Issued (Net) | 16.32M | 1.75M | 3.33M | 169.9M | 170.14M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 |
Other Financing | 1.27M | -2.54M | -4.54M | -5.71M | -35.6M |
Net Change in Cash | -55.38M▲ 0% | -52.48M▲ 5.2% | -39.25M▲ 25.2% | 145.64M▲ 471.1% | 152.37M▲ 0% |
Free Cash Flow | -71.7M▲ 0% | -52.66M▲ 26.6% | -38.04M▲ 27.8% | 16.93M▲ 144.5% | 21.45M▲ 0% |
FCF Margin % | -80.4% | -42.89% | -22.4% | 6.51% | 7.57% |
FCF Growth % | - | 26.56% | 27.76% | 144.5% | - |
FCF per Share | -1.29 | -0.94 | -0.68 | 0.29 | 0.36 |
FCF Conversion (FCF/Net Income) | 0.95x | 0.74x | 0.73x | -1.43x | -3.40x |
Interest Paid | 3.61M | 4.09M | 3.85M | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 |
OMDA Key Ratios
Omada Health (OMDA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|
Return on Equity (ROE) | -53.05% | -57.64% | -8.68% | -2.81% |
Return on Invested Capital (ROIC) | -307.92% | -202.83% | -68.89% | -35.94% |
Gross Margin | 56.99% | 60.59% | 65.69% | 66.22% |
Net Margin | -54.98% | -27.76% | -4.91% | -2.22% |
Debt / Equity | 0.31x | 0.47x | - | 0.00x |
Interest Coverage | -13.35x | -9.46x | -4.04x | -4.74x |
FCF Conversion | 0.74x | 0.73x | -1.43x | -3.40x |
Revenue Growth | 37.67% | 38.29% | 53.24% | - |
Related:OMDA Dividend History·OMDA Revenue History·OMDA Price History·OMDA P/E History·OMDA Financial Ratios·OMDA Institutional Holders
OMDA SEC Filings & Documents
Omada Health (OMDA) SEC filings — annual & quarterly reports (10-K, 10-Q)
OMDA Frequently Asked Questions
Omada Health (OMDA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Omada Health (OMDA) reported $283.3M in revenue for fiscal year 2025. This represents a 218% increase from $89.2M in 2022.
Omada Health (OMDA) grew revenue by 53.2% over the past year. This is strong growth.
Omada Health (OMDA) reported a net loss of $6.3M for fiscal year 2025.
Dividend & Returns
Omada Health (OMDA) has a return on equity (ROE) of -8.7%. Negative ROE indicates the company is unprofitable.
Omada Health (OMDA) generated $21.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.